H.R. 8687In committeeSecurity & foreign affairs
New fines target smuggled vapes lacking FDA approval
Data as of July 11, 2026
HR 8687 sets fines of $500–$5,000 per device for importing unapproved vaping products, with higher penalties for repeat or fraudulent violations.55-second read · 5 questions answered below
Decoded
What does this do?
HR 8687 creates financial penalties for importing vaping products that have not completed the FDA review process required for U.S. sale. Fines range from $500 per device for careless violations to $5,000 per device for intentional fraud. Total fines for a single shipment cannot exceed ten times the shipment's estimated U.S. retail value.
Who does it affect?
Importers, distributors, and businesses that bring unapproved vaping products into the United States are directly subject to these penalties. Consumers who vape could be indirectly affected if enforcement reduces the availability of certain products on the market.
Why does it matter?
Penalties increase further when smugglers route products through another country to conceal their origin or when a violator has been caught before. The bill treats companies linked by shared ownership or leadership as a single entity, preventing new business creation as a way to reset repeat-offender status.
What does it cost, and who pays?
- $500 per device — negligent violations
- $5,000 per device — intentional fraud
- Cap: 10× shipment retail value
Where does it stand?
- Introduced
- House committee — You are here
- House vote
- Senate
- President's desk
Right now: a House committee is reviewing it. If the Senate changes it, it goes back to the House before reaching the President.
AI-drafted summary. Verify it against the official text before you act on it.
Three steps: where you stand, your script, the call.
Make the callSee how a call works
Official title
ENDS Chinese Vapes Act of 2026
- Introduced:
- May 7, 2026
- Latest action:
- May 7, 2026
Referred to the House Committee on Ways and Means.
Read the official bill on Congress.govMake the call
Three steps: where you stand, your script, the call.